CV #14: About That $176M Grant That AbCellera Received From Ottawa….

1. Other Articles On CV “Planned-emic”

CLICK HERE, for #0: Theresa Tam; archives; articles; lobbying.
CLICK HERE, for #1: piece on Bill Gates, Pirbright, depopulation.
CLICK HERE, for #2: Coronavirus research at U of Saskatchewan.
CLICK HERE, for #3: Gates; WHO, ID2020; GAVI; Vaccines.
CLICK HERE, for #4: Gates using proxies to push vaxx agenda.
CLICK HERE, for #5: Crestview Strategy, GAVI’s lobbying firm.
CLICK HERE, for #6: people GAVI/Crestview lobbied follow Gates.
CLICK HERE, for #7: M-132, Canada financing pharma research.
CLICK HERE, for #8: Canada/WHO & “vaccine hesitancy” research.
CLICK HERE, for #9: Raj Saini, lobbied by big pharma (M-132).
CLICK HERE, for #10: pharma lobbying in Alberta legislature.
CLICK HERE, for #11: ON Pharma; Bill 160 Not Implemented.
CLICK HERE, for #12: 2006 report recommends surveillance/vaxx.
CLICK HERE, for #13: More on who Theresa Tam really is.

2. Important Links

CLICK HERE, for AbCellera’s website main page.
http://archive.is/ksLak
CLICK HERE, for the May 3, 2020 announcement.
http://archive.is/coqF2
CLICK HERE, for AbCellera’s list of partner companies.
http://archive.is/L9D7Y
CLICK HERE, for Navdeep Bains’ tweet announcing grant.
CLICK HERE, for AbCellera’s Twitter account.
http://archive.is/0cY5a

CLICK HERE, for AbCellera and the Federal Lobbying Commissioner.
http://archive.is/7w15g
CLICK HERE, for Merck & the Lobbying Commissioner.
http://archive.is/MljjW
CLICK HERE, for GAVI (Gates funded), & Lobbying Commissioner.
http://archive.is/zE7UT
CLICK HERE, for Novartis Pharmceuticals lobbying the Feds.
http://archive.is/zNBIw
CLICK HERE, for Pfizer and lobbying Federal Government.
http://archive.is/fdk5U
CLICK HERE, for GlaxoSmithKline lobbying Ottawa.
http://archive.is/Pfv86
CLICK HERE, for Sanofi Pasteur lobbying the Federal Government.
http://archive.is/szVu6

CLICK HERE, for Gates Foundation donates to AbCellera.
http://archive.is/0XZoT
CLICK HERE, for March 12 Nasdaq announcement for AbCellera.
http://archive.is/tey19

3. AbCellera’s May 3rd Announcement

VANCOUVER, British Columbia (May 3, 2020) – AbCellera announced today it has received a commitment of up to $175.6 million in support from the Government of Canada under Innovation, Science and Economic Development’s (ISED) Strategic Innovation Fund (SIF) to expand efforts related to the discovery of antibodies for use in drugs to treat COVID-19, and to build technology and manufacturing infrastructure for antibody therapies against future pandemic threats.

In addition to the support from the Government of Canada, AbCellera is receiving support from the City of Vancouver. “The City of Vancouver is fully committed to ensuring AbCellera has the infrastructure needed as they accelerate finding a treatment for COVID-19,” said Mayor Kennedy Stewart, City of Vancouver. “We couldn’t be more proud to be on the front lines of this global effort thanks to the innovation and leadership of AbCellera.”

AbCellera is a privately held Canadian biotech with a drug discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. AbCellera’s technology, which combines high-throughput microfluidics, big data, machine learning, bioinformatics and genomics, identifies new first-in-class drugs and reduces the time it takes to bring treatments to clinic. AbCellera’s partners include leading biotechnology companies, global health organizations and six of the top 10 biopharmaceutical companies. AbCellera was founded in 2012, and completed a Series A financing round in 2018, which was led by DCVC Bio. For more information, visit www.abcellera.com.

AbCellera announces a $175.6 million contribution from the Federal Government to finance research to develop a vaccine for the coronavirus. This was also shared across social media platforms such as Twitter.

By itself, it seems harmless enough. However, there is much more behind this transfer. Let’s get into it.

4. AbCellera’s Various Partners

  • Ablynx (a Sanofi company)
  • Autolus
  • Denali Therapeutics
  • Eli Lilly and Company
  • Gilead Sciences
  • GlaxoSmithKline
  • Global Health Foundation (Gates Foundation)
  • Kodiak Sciences
  • Lyell
  • Merck (MSD)
  • Novartis Pharmaceuticals
  • Pfizer Inc.
  • Sanofi Pasteur
  • Teva Pharmaceutical Industries, Ltd.

AbCellera Biologics partners with many pharma companies. They also work with the Bill & Melinda Gates Foundation, which is obviously pushing the vaccine agenda.

5. Lobbying CDN Federal Government

As of March 2020, AbCellera is registered with the Lobbying Commissioner’s Office. There are no communication reports — yet — but AbCellera is set up and ready to go and start lobbying. Also worth noting is that AbCellera received $289,116.00 from Western Economic Diversification Canada last year, and expects to receive more this year.

Merck has been lobbying the Federal Government since 2001, on a variety of pharmaceutical related issues. There are 103 listed communications reports. And they are a major partner for AbCellera Biologics.

This has been addressed in earlier parts of the series, but the Gates funded GAVI (Global Alliance for Vaccines and Immunizations) has been lobbying the Federal Government since 2018. There are 20 communications reports on file.

Novartis has been lobbying the Federal Government since 2007, and is one of AbCellera’s partners. There are 13 communications reports filed with the registry.

Since 2007, Pfizer, one of AbCellera’s partners, has 143 communications reports filed with the Lobbying Commissioner’s Office. It has operated under a few different corporate titles though.

There are 187 communications reports on file with the Office of the Lobbying Commissioner. Also noteworthy is that GlaxoSmithKline lobbies Provincially as well.

Sanofi is yet another one of AbCellera’s partners that has long been lobbying the Federal Government. Could have contributed to why AbCellera was able to get that $175.6 million contract from Ottawa.

Is it clear now? AbCellera Biologics was able to secure this contract because several of his partners have been lobbying Ottawa (not to mention Provincial Governments as well) for pharmaceutical related issues. Getting this bid seems pretty straight forward.

There are other partners who are involved in the lobbying, but this is already getting redundant, so we will move on to other topics.

6. Gates Gave AbCellera $645,000

In November 2016, the Bill & Melinda Gates Foundation gave AbCellera $645,000 to help develop antibodies to treat the tuberculosis infection. So when AbCellera is getting the current grant from the Canadian Government, is it really the Gates Foundation that is getting the money?

7. AbCellera Boosting The Nasdaq?

March 12 (Reuters) – Eli Lilly Co LLY.N and privately-held AbCellera Biologics Inc on Thursday announced they would co-develop antibody products for the treatment and prevention of COVID-19, a flu-like disease caused by the fast-spreading coronavirus.

With the collaboration, Lilly joins other drugmakers like Gilead Sciences Inc GILD.O and Biogen Inc BIIB.O in an attempt to develop a treatment for the disease which has caused more than 4,700 deaths globally.

“Our goal with AbCellera is to be testing potential new therapies in patients within the next four months,” Lilly’s Chief Scientific Officer Daniel Skovronsky said.

On March 12, Nasdaq.com announced that AbCellera and its partners would be working together to co-develop a vaccine for the coronavirus. The topic for another article, but it would be nice to dive in and see exactly who AbCellera Biologic’s donors are.

8. Heavy Lobbying Behind $175.6M Grant

The main take away from this is what many of AbCellera’s partners have been regularly and consistently lobbying the Federal Government. That Ottawa would hand out this kind of money is not surprising in the least.

To all readers: Know who is pushing the vaxx agenda. Know who is involved in influence peddling and cronyism. Our leaders are pushing for vaccines because they are puppets. Hopefully, some more details have become clear in this article.

Leave a Reply

Your email address will not be published. Required fields are marked *